Nasal delivery of single-domain antibodies improve symptoms of SARS-CoV-2 infection in an animal model
K. Haga, R. Takai-Todaka, Y. Matsumura…·K. Katayama
This paper shows nasal delivery of a camelid single-domain antibody reduces SARS-CoV-2 titers in hamsters without weight loss or cytokine induction.